News BioSpace: Cartesian Aims to Propel RNA Cell Therapy with Combinations Published: Jan 07, 2022 By Gail Dutton Cartesian Therapeutics is developing non-permanent cell therapies…Super UserJanuary 18, 2022
News Institute for Bioscience and Biotechnology Research Receives $16.8M Investment from the National Institute of Standards and Technology Fri, Jan 14, 2022 New Cooperative Agreement to Aid in the Development of Therapeutics…Super UserJanuary 18, 2022
News Unblock research bottlenecks with non-profit start-ups It takes more than a great idea to accomplish a great project. Our research and…Super UserJanuary 18, 2022
News Cartesian Aims to Propel RNA Cell Therapy with Combinations | BioSpace Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon after diagnosis and…Super UserJanuary 18, 2022
News South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine – Jan 12, 2022 -- Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine granted approval in…Super UserJanuary 18, 2022
News Chain Drug Review Pharmacy Outlook: Ronald Piervincenzi, USP January 10, 2022 by Ronald Piervincenzi The COVID-19 pandemic made the last year both an…Super UserJanuary 12, 2022
News Decentralized Clinical Trials Raise Concerns About Informed Consent Under pressure of the COVID-19 pandemic, multitudes of clinical trials of new medications and treatments…Super UserJanuary 12, 2022
News REGENXBIO Announces Initiation of Second Pivotal Trial in RGX-314 Clinical Program for the Treatment of Wet AMD Using Subre… ROCKVILLE, Md., Jan. 10, 2022 /PRNewswire/ -- ASCENTTM, a Phase III clinical trial conducted in…Super UserJanuary 10, 2022
News MIMETAS opens Phenotypic Screening Center Leiden, May 27, 2021 - MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just…Super UserJanuary 10, 2022